Perceptions of GLP-1 RA Use for Children With Obesity Among Caregivers With Food Insecurity

JAMA Network Open 2026 Open access

Read full text
Authors: Kathryn M. Stephenson, Naomi R. M. Schwartz, Hannibal Person, Niviann M. Blondet, Maria Benitez-Cortez, Mason Nuding, Stephanie A. Kraft, David L. Suskind
DOI: 10.1001/jamanetworkopen.2025.52825
Cited by: 0
References: 26

Abstract

Importance: With the approval of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for pediatric obesity, families are increasingly considering pharmaceutical treatment alongside lifestyle optimization for their children, although how caregivers will make these decisions remains unexplored. This is especially important in contexts where food insecurity may limit the feasibility of lifestyle change and adjunct therapy could improve outcomes. Objective: To explore how caregivers make decisions regarding the inclusion of GLP-1 RAs for pediatric obesity treatment in the context of food insecurity. Design, Setting, and Participants: In this qualitative study, eligible participants were caregivers (aged ≥18 years) of children (aged

Fields of Study & Subjects

Food Security and Health in Diverse Populations Obesity Physical Activity Diet Obesity and Health Practices

Publication details

Journal / source
JAMA Network Open
Volume
9
Issue
1
Pages
e2552825–e2552825
Publication date
7 January 2026
Language
EN